Abbott Laboratories Share Price CBOE
Stocks
ABT
US0028241000
Medical Equipment, Supplies & Distribution
|
Real-time
CBOE
19:42:05 21/09/2026 BST
|
5-day change | 1st Jan Change | ||
| 103.00 USD | +0.46% |
|
+0.54% | -18.15% |
| 05:42pm | Grail rallies as FDA staff flags no major concerns for multi-cancer test | RE |
| 09-18 | Trinity Heart Experts First in the Quad Cities to Use New Afib Technology | CI |
| Market Cap | 178B 155B 146B 133B 249B 17,010B 249B 1,746B 673B 8,665B 667B 652B 27,961B | P/E 2026 * |
29.1x | P/E 2027 * | 22.5x |
|---|---|---|---|---|---|
| Enterprise Value | 201B 176B 165B 151B 283B 19,304B 283B 1,982B 764B 9,833B 757B 740B 31,731B | EV / Sales 2026 * |
4.01x | EV / Sales 2027 * | 3.64x |
| Free-Float |
86.16% | Yield 2026 * |
2.51% | Yield 2027 * | 2.67% |
| Markets | Quality | ||
|---|---|---|---|
NYSE
| ABT | Delayed | |
CBOE
| ABT | Real-time | |
|
Tradegate
| ABL | Real-time | |
|
Xetra
| ABL | Delayed | |
|
Boerse Muenchen
| ABL | Real-time | |
|
CBOE
| Real-time | ||
|
Borsa Italiana
| 1ABT | End-of-day quote | |
|
CBOE
| ABT | Real-time | |
|
London S.E.
| ABT | Delayed | |
|
Börse Stuttgart
| ABL | Delayed | |
|
Mexican S.E.
| ABT * | End-of-day quote | |
|
Deutsche Boerse AG
| ABL | Delayed | |
|
Kazakhstan S.E.
| ABT_KZ | End-of-day quote | |
|
Lima
| ABTUS | End-of-day quote | |
|
Swiss Exchange
| ABT | Delayed | |
|
Wiener Boerse
| ABT | End-of-day quote | |
|
Santiago S.E.
| ABTCL | End-of-day quote | |
|
Santiago S.E.
| ABT | End-of-day quote |
Last Transcript: Abbott Laboratories
| 1 week | +0.54% | ||
| Current month | -7.13% | ||
| 1 month | -9.03% | ||
| 3 months | +15.98% | ||
| 6 months | -5.50% | ||
| Current year | -18.15% |
| 1 week | 100.39 |  | 104.37 |
| 1 month | 100.39 | | 117.34 |
| 3 years | 81.98 | | 141.08 |
| 5 years | 81.98 | | 142 |
| 10 years | 37.38 | | 142 |
| Manager | Title | Age | Since |
|---|---|---|---|
Robert Ford
CEO | Chief Executive Officer | 52 | 30/03/2020 |
Philip Boudreau
DFI | Director of Finance/CFO | 53 | 31/08/2023 |
Sabina Ewing
CIO | Chief Investment Officer | 51 | - |
| Director | Title | Age | Since |
|---|---|---|---|
Sally Blount
BRD | Director/Board Member | 64 | 08/12/2011 |
Nancy McKinstry
BRD | Director/Board Member | 67 | 08/12/2011 |
Daniel Starks
BRD | Director/Board Member | 71 | 15/02/2017 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.46% | +0.54% | -23.80% | +1.52% | 178B | |
| +0.39% | -0.26% | -24.74% | +3.93% | 178B | |
| -0.10% | -2.00% | -2.85% | +14.24% | 118B | |
| +2.29% | -3.11% | +9.45% | +70.91% | 58.92B | |
| +0.10% | -1.17% | -3.10% | -31.79% | 49.29B | |
| -0.22% | -0.37% | +10.27% | +42.75% | 48.17B | |
| +0.23% | +5.47% | +28.49% | +0.26% | 33.72B | |
| +0.21% | -2.76% | - | - | 27.76B | |
| +0.30% | +2.16% | +43.87% | -3.05% | 25.5B | |
| +1.77% | +9.57% | +9.06% | -13.10% | 22.1B | |
| Average | +0.54% | +1.65% | +5.18% | +9.52% | 62.32B | |
| Weighted average by Cap. | +0.43% | +0.95% | -8.13% | +9.79% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 50.2B 43.77B 41.23B 37.55B 70.39B 4,810B 70.48B 494B 190B 2,450B 189B 184B 7,906B | 54.53B 47.54B 44.78B 40.78B 76.46B 5,224B 76.55B 536B 207B 2,661B 205B 200B 8,587B |
| Net income | 6.3B 5.5B 5.18B 4.71B 8.84B 604B 8.85B 61.99B 23.89B 308B 23.68B 23.15B 993B | 7.98B 6.96B 6.55B 5.97B 11.19B 764B 11.2B 78.46B 30.24B 389B 29.97B 29.3B 1,256B |
| Net Debt | 23.94B 20.87B 19.66B 17.9B 33.57B 2,293B 33.61B 235B 90.74B 1,168B 89.92B 87.93B 3,770B | 20.96B 18.27B 17.21B 15.67B 29.39B 2,008B 29.42B 206B 79.44B 1,023B 78.72B 76.98B 3,300B |
| Date | Price | Change |
|---|---|---|
| 21/09/26 | US$103.00 | +0.46% |
| 18/09/26 | US$102.53 | +0.28% |
| 17/09/26 | US$102.24 | -0.12% |
| 16/09/26 | US$102.36 | +0.35% |
| 15/09/26 | US$102.00 | -1.08% |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- ABT Stock
- ABT Stock
Select your edition
All financial news and data tailored to specific country editions
